Evidence map›Paper›PMID 40757632›Full record

ReviewAnnals of the New York Academy of Sciences2025

Leveraging chemical synthesis to discover metabolites from the gut microbiome.

Allison J Keys, Nitesh K Nandwana, Eyas Alnasser, Emily C Gentry

Abstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Allison J Keys *Department of Chemistry, Virginia Tech, Blacksburg, Virginia, USA.
Nitesh K Nandwana *Department of Chemistry, Virginia Tech, Blacksburg, Virginia, USA.
Eyas AlnasserDepartment of Chemistry, Virginia Tech, Blacksburg, Virginia, USA.
Emily C GentryDepartment of Chemistry, Virginia Tech, Blacksburg, Virginia, USA.ORCID 0000-0002-0016-8132

Funding

Mapping the Human Metabolome Using Synthesis and Mass SpectrometryR35GM154990 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI EMILY GENTRY · 2024 to 2026
$1.2M
NIGMS NIH HHS R35 GM154990NIH HHS R35GM154990
6 · The paper itself

Abstract

The gut microbiome has the biosynthetic potential to make a variety of secondary metabolites or natural products, which serve as molecular messages between cells and organisms. These chemical signals are capable of affecting physiology and behavior in real time, and are, therefore, bioactive and can exhibit medicinal properties including anticancer, antimicrobial, or immunomodulating activities. It is clearly important to identify signaling molecules in the human gut, but elucidating their chemical structures can be challenging since traditional isolation methods are typically not available. The discovery of microbiome-related metabolites requires multidisciplinary collaboration, where chemical synthesis often plays an essential role. This review highlights examples where synthetic chemistry was used to study novel metabolites produced by the gut microbiota. In the first part, we describe examples where organic synthesis was utilized in traditional contexts, as a last step for validating structures and sourcing material for biological testing. The final section of this review discusses next-generation applications for chemical synthesis, where integration with metabolomic or genomic analysis simultaneously uncovers both structural and biological information about small molecules from the gut.

Indexed as

Biological ProductsGastrointestinal MicrobiomeAnimalsHumansMetabolomicsBiological Productsgut microbiomemass spectrometrymetabolite discoverymetabolomicsorganic synthesisreverse metabolomicssynthetic chemistry

Identifiers

PMID40757632
PMCPMC12327764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.